Patent details

EP3630112 Title: COMBINATION OF REGORAFENIB AND NIVOLUMAB FOR TREATING CANCER

Basic Information

Publication number:
EP3630112
PCT Application Number:
EP2018063785
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187252580
PCT Publication Number:
WO2018219807
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF REGORAFENIB AND NIVOLUMAB FOR TREATING CANCER
French Title of Invention:
COMBINAISON DE RÉGORAFÉNIB ET NIVOLUMAB POUR LE TRAITEMENT DU CANCER
German Title of Invention:
KOMBINATION AUS REGORAFENIB UND NIVOLUMAB ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
25/05/2018
Grant date:
31/01/2024
EP Publication Date:
08/04/2020
PCT Publication Date:
06/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2024
EP B1 Publication Date:
31/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/05/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/01/2024
 
 

Name:
Bayer HealthCare LLC
Address:
100 Bayer Boulevard, Whippany, NJ 07981, United States (US)

Agent

Name:
ARONOVA S.A.
From:
16/04/2024
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
ZOPF, Dieter
Address:
Germany (DE)

2

Name:
RÖSE, Lars
Address:
Germany (DE)

3

Name:
HOFF, Sabine
Address:
Germany (DE)

4

Name:
LEDERLE, Wiltrud
Address:
Germany (DE)

5

Name:
DOLESCHEL, Dennis
Address:
Netherlands (NL)

6

Name:
KIESSLING, Fabian
Address:
Germany (DE)

Priority

Priority Number:
17174169
Priority Date:
02/06/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/44; A61K 31/395; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202405
Publication date:
31/01/2024
Description:
Grant (B1)

2

Issue number:
202406
Publication date:
07/02/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202426
Publication date:
26/06/2024
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
16/04/2024 Power Of Attorney 1
16/04/2024 Outgoing Correspondence 1